Changes of thromboxane B2 following to lung collapse during thoracotomy

Changes of thromboxane B2 following to lung collapse during thoracotomy - Changes of thromboxane B2 following to lung collapse during thoracotomy

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000034950

Enrollment

Registered

2018-11-20

Start date

2018-11-02

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer

Interventions

Remifentanil and Flurbiprofen axytil Fentanyl Remifentanil

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Cases of elective lung resection of lung cancer under one lung ventilation anesthesia

Exclusion criteria

Exclusion criteria: Renal dysfunction (Serum creatinine>1.3mg/dL), history of non-steroidal antiinflammatory agent allergy, history of asthma

Design outcomes

Primary

Measure	Time frame
Serum thromboxane B2 concentration(Before lung collapse, 15 minutes after lung collapse, 60 minutes after lung collapse)	—

Secondary

Measure	Time frame
Serum prostaglandin F1 alfa (Before lung collapse, 15 minutes after lung collapse, 60 minutes after lung collapse): measured in the study registered as UMIN000028856	—

Countries

Japan

Contacts

Public ContactHiromi Katoh

Hyogo Cancer Center Department of Anesthesia

whoami@hp.pref.hyogo.jp078-929-1151

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026